SK Bioscience Co Ltd
KRX:302440
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
46 950
73 300
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one SK Bioscience Co Ltd stock under the Base Case scenario is 38 899.82 KRW. Compared to the current market price of 46 950 KRW, SK Bioscience Co Ltd is Overvalued by 17%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
SK Bioscience Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for SK Bioscience Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
SK Bioscience Co Ltd
Balance Sheet Decomposition
SK Bioscience Co Ltd
Current Assets | 1.4T |
Cash & Short-Term Investments | 1.2T |
Receivables | 30.6B |
Other Current Assets | 134.7B |
Non-Current Assets | 587.2B |
Long-Term Investments | 101.2B |
PP&E | 386B |
Intangibles | 21.6B |
Other Non-Current Assets | 78.3B |
Current Liabilities | 136.2B |
Accounts Payable | 11.4B |
Accrued Liabilities | 10.1B |
Other Current Liabilities | 114.8B |
Non-Current Liabilities | 92.4B |
Long-Term Debt | 91.8B |
Other Non-Current Liabilities | 618.8m |
Earnings Waterfall
SK Bioscience Co Ltd
Revenue
|
371.5B
KRW
|
Cost of Revenue
|
-213.1B
KRW
|
Gross Profit
|
158.4B
KRW
|
Operating Expenses
|
-155.1B
KRW
|
Operating Income
|
3.3B
KRW
|
Other Expenses
|
24.1B
KRW
|
Net Income
|
27.4B
KRW
|
Free Cash Flow Analysis
SK Bioscience Co Ltd
KRW | |
Free Cash Flow | KRW |
Profitability Score
Profitability Due Diligence
SK Bioscience Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
SK Bioscience Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
SK Bioscience Co Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Score
SK Bioscience Co Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
SK Bioscience Co Ltd
According to Wall Street analysts, the average 1-year price target for SK Bioscience Co Ltd is 50 150 KRW with a low forecast of 35 350 KRW and a high forecast of 63 000 KRW.
Dividends
Current shareholder yield for SK Bioscience Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
SK bioscience Co., Ltd. engages in the development and distribution of bio and vaccine products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-03-18. The firm's main products include vaccines such as SKYCellflu and Rotatech. The firm also sells infusion solutions. In addition, the Company engages in technology export business. The firm sells its products in domestic and overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one SK Bioscience Co Ltd stock under the Base Case scenario is 38 899.82 KRW.
Compared to the current market price of 46 950 KRW, SK Bioscience Co Ltd is Overvalued by 17%.